123 related articles for article (PubMed ID: 9518049)
1. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
Gordon SG; Mielicki WP
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
[TBL] [Abstract][Full Text] [Related]
2. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
3. Cancer procoagulant--CP.
Rucińska M; Gacko M; Skrzydlewski Z
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
[TBL] [Abstract][Full Text] [Related]
4. [Cancer procoagulant (CP)].
Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
[TBL] [Abstract][Full Text] [Related]
5. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
6. Effect of divalent ions on the activity of cancer procoagulant.
Mielicki WP; Kozwich DL; Kramer LC; Gordon SG
Arch Biochem Biophys; 1994 Oct; 314(1):165-70. PubMed ID: 7944389
[TBL] [Abstract][Full Text] [Related]
7. Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of "in vitro" culture.
Pacchiarini L; Meloni F; Zucchella M; Mangiarotti P; Tacconi F; Ballabio P; Grignani G
Haematologica; 1991; 76(5):392-7. PubMed ID: 1806443
[TBL] [Abstract][Full Text] [Related]
8. Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro.
Kamocka M; Rózalski M; Krajewska U; Wierzbicki R; Mielicki WP
Cancer Lett; 2005 May; 222(1):89-94. PubMed ID: 15837545
[TBL] [Abstract][Full Text] [Related]
9. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Kaplinska K; Mielicki WP
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531
[TBL] [Abstract][Full Text] [Related]
10. Coagulation activation by MC28 fibrosarcoma cells facilitates lung tumor formation.
Amirkhosravi M; Francis JL
Thromb Haemost; 1995 Jan; 73(1):59-65. PubMed ID: 7740497
[TBL] [Abstract][Full Text] [Related]
11. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
Gordon SG; Cross BA
Cancer Res; 1990 Oct; 50(19):6229-34. PubMed ID: 2169340
[TBL] [Abstract][Full Text] [Related]
12. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
[TBL] [Abstract][Full Text] [Related]
13. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
[TBL] [Abstract][Full Text] [Related]
14. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of the efficacy of cancer procoagulant (CP) activity evaluation in the oncological diagnosis of the urinary system].
Szajda SD; Darewicz B; Kudelski J; Werel T; Zwierz K; Skrzydlewski Z; Gabrylewski W
Pol Merkur Lekarski; 2005 Oct; 19(112):596-9. PubMed ID: 16379335
[TBL] [Abstract][Full Text] [Related]
16. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
17. Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice.
Donati MB
Thromb Haemost; 1995 Jul; 74(1):278-81. PubMed ID: 8578472
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
Kamocka M; Kaplinska K; Mielicki WP
Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
[TBL] [Abstract][Full Text] [Related]
19. New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors.
Mielicki WP; Tagawa M; Gordon SG
Thromb Haemost; 1994 Apr; 71(4):456-60. PubMed ID: 8052963
[TBL] [Abstract][Full Text] [Related]
20. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
